198 related articles for article (PubMed ID: 2032228)
1. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb.
Melani C; Rivoltini L; Parmiani G; Calabretta B; Colombo MP
Cancer Res; 1991 Jun; 51(11):2897-901. PubMed ID: 2032228
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of proliferation by c-myb antisense RNA and oligodeoxynucleotides in transformed neuroectodermal cell lines.
Raschellà G; Negroni A; Skorski T; Pucci S; Nieborowska-Skorska M; Romeo A; Calabretta B
Cancer Res; 1992 Aug; 52(15):4221-6. PubMed ID: 1638535
[TBL] [Abstract][Full Text] [Related]
3. Myb expression is higher in malignant human colonic carcinoma and premalignant adenomatous polyps than in normal mucosa.
Ramsay RG; Thompson MA; Hayman JA; Reid G; Gonda TJ; Whitehead RH
Cell Growth Differ; 1992 Oct; 3(10):723-30. PubMed ID: 1445802
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite deletions in the c-myb transcriptional attenuator region associated with over-expression in colon tumour cell lines.
Thompson MA; Flegg R; Westin EH; Ramsay RG
Oncogene; 1997 Apr; 14(14):1715-23. PubMed ID: 9135073
[TBL] [Abstract][Full Text] [Related]
5. Quantifying c-myc expression in c-myc antisense phosphorothioate oligodeoxynucleotide-treated leukemic and colon cancer cell lines.
Li BD; Budnick RM; Russo CA; Anderson GR; Stewart CC
J Surg Res; 1995 Oct; 59(4):485-92. PubMed ID: 7564322
[TBL] [Abstract][Full Text] [Related]
6. c-Myb down-regulation is associated with human colon cell differentiation, apoptosis, and decreased Bcl-2 expression.
Thompson MA; Rosenthal MA; Ellis SL; Friend AJ; Zorbas MI; Whitehead RH; Ramsay RG
Cancer Res; 1998 Nov; 58(22):5168-75. PubMed ID: 9823328
[TBL] [Abstract][Full Text] [Related]
7. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
Ramachandran C; Wellham LL
Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of caveolin-1 in experimental colon adenocarcinomas and human colon cancer cell lines.
Patlolla JM; Swamy MV; Raju J; Rao CV
Oncol Rep; 2004 May; 11(5):957-63. PubMed ID: 15069532
[TBL] [Abstract][Full Text] [Related]
9. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
Nesterova M; Noguchi K; Park YG; Lee YN; Cho-Chung YS
Clin Cancer Res; 2000 Sep; 6(9):3434-41. PubMed ID: 10999726
[TBL] [Abstract][Full Text] [Related]
10. Constitutive versus cell cycle regulation of c-myb mRNA expression correlates with developmental stages in murine B lymphoid tumors.
Catron KM; Purkerson JM; Isakson PC; Bender TP
J Immunol; 1992 Feb; 148(3):934-42. PubMed ID: 1730880
[TBL] [Abstract][Full Text] [Related]
11. Oncogene expression in adenocarcinomas of the colon and in colon tumor-derived cell lines.
Untawale S; Blick M
Anticancer Res; 1988; 8(1):1-7. PubMed ID: 3282475
[TBL] [Abstract][Full Text] [Related]
12. The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines.
Erisman MD; Scott JK; Watt RA; Astrin SM
Oncogene; 1988 Apr; 2(4):367-78. PubMed ID: 3283655
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions.
Guo YS; Jin GF; Townsend CM; Zhang T; Sheng HM; Beauchamp RD; Thompson JC
J Am Coll Surg; 1995 Aug; 181(2):145-54. PubMed ID: 7627387
[TBL] [Abstract][Full Text] [Related]
14. Met/HGF receptor modulates bcl-w expression and inhibits apoptosis in human colorectal cancers.
Kitamura S; Kondo S; Shinomura Y; Kanayama S; Miyazaki Y; Kiyohara T; Hiraoka S; Matsuzawa Y
Br J Cancer; 2000 Sep; 83(5):668-73. PubMed ID: 10944610
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of MDR1 gene expression by antimessenger oligonucleotides lowers multiple drug resistance.
Quattrone A; Papucci L; Morganti M; Coronnello M; Mini E; Mazzei T; Colonna FP; Garbesi A; Capaccioli S
Oncol Res; 1994; 6(7):311-20. PubMed ID: 7865906
[TBL] [Abstract][Full Text] [Related]
16. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.
Campbell-Thompson M; Lynch IJ; Bhardwaj B
Cancer Res; 2001 Jan; 61(2):632-40. PubMed ID: 11212261
[TBL] [Abstract][Full Text] [Related]
17. The insulin-like growth factor 1 receptor is required for the proliferation of hemopoietic cells.
Reiss K; Porcu P; Sell C; Pietrzkowski Z; Baserga R
Oncogene; 1992 Nov; 7(11):2243-8. PubMed ID: 1359494
[TBL] [Abstract][Full Text] [Related]
18. Acyclic retinoid, a novel synthetic retinoid, induces growth inhibition, apoptosis, and changes in mRNA expression of cell cycle- and differentiation-related molecules in human colon carcinoma cells.
Suzui M; Sunagawa N; Chiba I; Moriwaki H; Yoshimi N
Int J Oncol; 2006 May; 28(5):1193-9. PubMed ID: 16596235
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of S19 ribosomal protein, laminin-binding protein, and human lymphocyte antigen class I messenger RNAs associated with colon carcinoma progression and differentiation.
Kondoh N; Schweinfest CW; Henderson KW; Papas TS
Cancer Res; 1992 Feb; 52(4):791-6. PubMed ID: 1339304
[TBL] [Abstract][Full Text] [Related]
20. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells.
Kamano H; Tanaka T; Ohnishi H; Kubota Y; Ikeda K; Takahara J; Irino S; Ottalenghi S
Biochem Mol Biol Int; 1994 Aug; 34(1):85-92. PubMed ID: 7849628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
